Max Healthcare Reports Growth in FY26 Fourth Quarter Amid Strategic Expansion

Max Healthcare Institute has released its financial results for the fourth quarter of the 2026 fiscal year, highlighting a period of steady growth despite margin pressures stemming from regulatory changes and investments in clinical talent. The Delhi-based hospital chain reported a consolidated net profit of ₹342 crore for the quarter ending March 2026, marking a 7.2 percent year-on-year increase from the ₹319 crore recorded in the same period of the previous year.

Financial Performance and Operational Metrics

The company’s revenue from operations reached ₹2,143 crore, representing a 12 percent growth compared to ₹1,909 crore in Q4 FY25. This revenue trajectory was supported by an 8 percent year-on-year rise in occupied bed days (OBDs) and continued demand from international patients.

According to the company’s investor presentation, revenue specifically attributed to international patients climbed 12 percent year-on-year to ₹227 crore, accounting for approximately 9 percent of total hospital revenue. The daily average revenue per occupied bed day (ARPOB) remained relatively stable at ₹77,900, compared to ₹77,100 in the prior-year period.

When considering the broader entity—including three partner healthcare facilities in New Delhi (Max Balaji Hospital, Max Smart Super Speciality Hospital, and Max Saket Super Speciality Hospital) that are excluded from the consolidated financial statements—the revenue figure adjusts to ₹2,563 crore, with a corresponding net profit of ₹387 crore.

Margin Compression and Strategic Investments

While the company saw growth in its top and bottom lines, operating margins experienced a slight contraction. Earnings before interest, tax, depreciation, and amortisation (EBITDA) rose 8 percent to ₹682 crore. However, the operating margin slipped to 26.8 percent, down from 27.2 percent in the previous year.

The firm attributed this margin compression to a 230-basis-point increase in clinician costs. Management noted that this rise is a direct result of an aggressive strategy to recruit high-quality clinical talent necessary to support the company’s ongoing capacity expansions and long-term growth objectives.

Looking Ahead: Capacity Expansion

Abhay Soi, Chairman and Managing Director at Max Healthcare, emphasized that the company is currently in the midst of a significant expansion phase. The organization has initiated the phased commissioning of brownfield projects across Mohali, Mumbai, and Delhi, which represent an approximate 20 percent increase in total capacity.

Looking further into the future, the company plans to add another 10 percent to its capacity through the commissioning of a greenfield facility in Gurgaon, expected to be operational by the end of the year.

Key Takeaways

• Net Profit Growth: Consolidated net profit rose 7.2 percent year-on-year to ₹342 crore.
• Revenue Gains: Revenue from operations increased 12 percent, bolstered by international patient demand and higher bed occupancy.
• Strategic Costs: Operating margins were impacted by a 230-basis-point increase in clinician hiring costs.
• Expansion Focus: The company is actively commissioning brownfield projects and preparing for a new greenfield facility in Gurgaon.

Following the release of these results, Max Healthcare’s shares saw positive movement, ending the day on the BSE at ₹1,091.55, an intraday increase of 1.42 percent.